Literature DB >> 18053402

Cluster of Mycobacterium fortuitum prosthetic joint infections.

Lisa Cornelius1, Robert Reddix, Christine Burchett, Greg Bond, Robert Fader.   

Abstract

Mycobacterium fortuitum is a member of the rapidly growing nontuberculous mycobacteria. Although mortality is rare from M. fortuitum, morbidity depends on the localized site of infection. M. fortuitum is ubiquitous in the environment and has been reported to cause infections of prosthetic devices. There have been seven previously reported cases of prosthetic joint infections due to M. fortuitum. This article presents three additional cases of postoperative joint infections due to M. fortuitum. All three cases were confirmed to be genetically indistinguishable by pulse-field gel electrophoresis. Awareness of its importance is especially noteworthy in the realm of ongoing antibiotic resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18053402

Source DB:  PubMed          Journal:  J Surg Orthop Adv        ISSN: 1548-825X


  4 in total

Review 1.  Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteria.

Authors:  R J Kothavade; R S Dhurat; S N Mishra; U R Kothavade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-11-09       Impact factor: 3.267

2.  Rapidly-growing mycobacterial infection: a recognized cause of early-onset prosthetic joint infection.

Authors:  Anupop Jitmuang; Varah Yuenyongviwat; Keerati Charoencholvanich; Methee Chayakulkeeree
Journal:  BMC Infect Dis       Date:  2017-12-28       Impact factor: 3.090

Review 3.  Methods of phenotypic identification of non-tuberculous mycobacteria.

Authors:  Gurpreet S Bhalla; Manbeer S Sarao; Dinesh Kalra; Kuntal Bandyopadhyay; Arun Ravi John
Journal:  Pract Lab Med       Date:  2018-07-18

4.  Outbreak of Nontuberculous Mycobacteria Joint Prosthesis Infections, Oregon, USA, 2010-2016.

Authors:  Genevieve L Buser; Matthew R Laidler; P Maureen Cassidy; Heather Moulton-Meissner; Zintars G Beldavs; Paul R Cieslak
Journal:  Emerg Infect Dis       Date:  2019-05       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.